1. World Health Organization. Cardiovascular Diseases. 2022, https://www.who.int/health-topics/cardiovascular-diseases#tab=tab_1.
2. National Center for Cardiovascular Diseases, China. Annual Report on Cardiovascular Health and Diseases in China (2021) (in Chinese). Beijing: Science Press, 2022. 110–112 [国家心血管病中心. 中国心血管健康与疾病报告2021. 北京: 科学出版社, 2022. 110–112].
3. Kumar S, Singh S K, Rana B. The regulatory function of mixed lineage kinase 3 in tumor and host immunity. Pharmacol Ther, 2021, 219:
4. Ing Y L, Leung I W, Heng H H, et al. MLK-3: Identification of a widely-expressed protein kinase bearing an SH3 domain and a leucine zipper-basic region domain. Oncogene, 1994, 9: 1745–1750.
5. Saminathan P, Kevadiya B D, Marker D F. Broad spectrum mixed lineage kinase type 3 inhibition and HIV-1 persistence in macrophages. J Neuroimmune Pharm, 2019, 14: 44-51.